Back to top
more

Tema Obesity & Cardiometabolic ETF: (HRTS)

(Delayed Data from NASDAQ) As of May 17, 2024 04:00 PM ET

$32.67 USD

32.67
8,621

-0.23 (-0.70%)

Volume: 8,621

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $32.57 -0.10 (-0.31 %) 7:58 PM ET

ETF Quote Details

Previous Close 32.90
Open 32.87
Bid 27.00
Ask 32.97
Day Low-High 32.50-32.87
52wk Low-High 26.26-35.58
Volume 8,621
NAV (month end) 31.19
Premium (+)/Discount (-) (month end)+1.71

Zacks Premium Research for HRTS

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA

ETF Expense Ratio

Expense Ratio 0.75%
Dividend (Yield) $0.00 (0.00%)
Issuer TEMA

Benchmark for HRTS

----------------------------------------

This ETF is active and does not track a benchmark.

Fund Summary for HRTS

TEMA OBESITY & CARDIOMETABOLIC ETF

The Tema Obesity & Cardiometabolic ETF seeks to provide long-term growth of capital by investing in companies leading the fight against obesity and cardiometabolic diseases.